(Q57244167)

1

0 references

B. E.J. Teunissen

2

0 references

P. H.M. Willemsen

3

0 references

F. A. van Nieuwenhoven

4

0 references

A. E. Brouns

5

0 references

B. J.A. Janssen

6

0 references

J. P.M. Cleutjens

7

0 references

G. J. van der Vusse

9

0 references

M. van Bilsen

Cardiac hypertrophy: the good, the bad, and the ugly

10

0 references

publication date

10 January 2008

0 references

published in

Cardiovascular Research

0 references

volume

78

0 references

issue

1

0 references

page(s)

79-89

0 references

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN001

Controversies in ventricular remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN001

Tumor necrosis factor alpha induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN001

IL-1beta and TNF-alpha upregulate angiotensin II type 1 (AT1) receptors on cardiac fibroblasts and are associated with increased AT1 density in the post-MI heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN001

Inhibition of NF-kappaB induces regression of cardiac hypertrophy, independent of blood pressure control, in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN001

Cardioprotection afforded by NF-kappaB ablation is associated with activation of Akt in mice overexpressing TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN001

Nuclear receptors versus inflammation: mechanisms of transrepression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN001

Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN001

Peroxisome proliferator-activated receptors: lipid binding proteins controling gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN001

PPAR alpha activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN001

Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN001

Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN001

Long-term structural and functional consequences of cardiac ischaemia-reperfusion injury in vivo in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN001

Activation of PPARdelta inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN001

qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN001

Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN001

A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN001

Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN001

Decreased contractile and metabolic reserve in peroxisome proliferator-activated receptor-alpha-null hearts can be rescued by increasing glucose transport and utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN001

PPAR-alpha activation required for decreased glucose uptake and increased susceptibility to injury during ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN001

A critical role for peroxisomal proliferator-activated receptor-alpha nuclear receptors in the development of cardiomyocyte degeneration and necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN001

Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN001

Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN001

Peroxisome proliferator activated receptor (PPAR)alpha agonists inhibit hypertrophy of neonatal rat cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN001

Peroxisome proliferator-activated receptor alpha-independent actions of fenofibrate exacerbates left ventricular dilation and fibrosis in chronic pressure overload.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN001

Cardiac fatty acid metabolism is preserved in the compensated hypertrophic rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN001

NF-kappaB activation is required for the development of cardiac hypertrophy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN001

Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN001

Role of oxidative stress in cardiac dysfunction of PPARα−/− mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN001